21 November 2024

Howe Street Reporter Title

Category: Mushrooms

  • Multi-Company Wrap: Watching the watchlist so you don’t have to

    Multi-Company Wrap: Watching the watchlist so you don’t have to

    We have some 29 companies on our watchlist, all in a variety of sectors, that we’re covering at any one time. Some are clients, some not, some are on deaths door, some are skyrocketing, so we’ve decided to wrap them all up into one monthly wrap so you can keep track of everything at once.…

  • Today’s Idea: Filament Health’s (FH.NE) psychedelics play

    Today’s Idea: Filament Health’s (FH.NE) psychedelics play

    Our Psychedelic Trip Isn’t Over I don’t know the first thing about psychedelics. Rather, that’s what I would have been saying back in 2020 when the psychedelics sector was experiencing an unprecedented breakout period. Maybe it was because of mainstream media or perhaps it was my nagging parents, but I have always feared psychedelics. Back…

  • Today’s Idea: Filament Health (FH.NE) Is All Natural

    Today’s Idea: Filament Health (FH.NE) Is All Natural

    Natural Talent Albert Hofmann was a fun guy, pun intended. More importantly, the Swiss chemist is known for being the first person to synthesize, consume, and learn of the psychedelic effects of lysergic acid diethylamide (LSD). Truly a mad chemist. Furthermore, Hofmann was also the first person to isolate, synthesize, and name the principal psychedelic compounds…

  • Mydecine Innovations (MYCO.NEO) is operating on the leading edge of mental health & addiction treatment

    Mydecine Innovations (MYCO.NEO) is operating on the leading edge of mental health & addiction treatment

    On February 16, 2022 Mydecine Innovations Group (MYCO.NEO) announced the inclusion of a novel molecule with potentially heart-safe microdose enabling properties in their family of psilocin analogs. Founded in 2020, Mydecine Innovations is a biotechnology company developing therapeutics to treat unmet needs in mental health and addiction disorders. Focusing on psychedelic compounds with therapeutic potential,…

  • Today’s Idea: Filament Health (FH.NE) Gaining Traction

    Today’s Idea: Filament Health (FH.NE) Gaining Traction

    Problematic Psychedelics? Psychedelics and mental health treatment go together like orange juice and toothpaste. That’s what I would have said five years ago. Prior to the publication of multiple peer-reviewed studies, I adamantly believed psychedelics would melt your brain. In retrospect, that belief is just about as bogus as going to hell for premarital hand-holding.…

  • Market positivity leads to psychedelic space love, is the sector slump over? – Today’s Idea

    Market positivity leads to psychedelic space love, is the sector slump over? – Today’s Idea

    We’re not out of the woods yet, but the major indices are turning green again and psychedelics, recently a relative investment pariah, are getting some love from investors. The appreciation isn’t absolute, but many companies in the space are experiencing a much-needed bump. I want to focus on four psychedelics companies, each pursuing a different…

  • MYND Life Sciences (MYND.C) provides unorthodox route to better mental health

    MYND Life Sciences (MYND.C) provides unorthodox route to better mental health

    We’re living in interesting times and I mean that in the Chinese curse kind of way. We can’t seem to stop to catch our breath when it comes to this pandemic, and the news sources we trust to keep us informed can’t seem to get the story straight. The result is more isolation, frustration, and…

  • If I had a billion dollars: psychedelics sector edition

    If I had a billion dollars: psychedelics sector edition

    The Bare Naked Ladies made “if I had a million dollars,” famous, as they tunefully explained what they would do with their riches. However, in the post-crisis everything bubble, that speculative fantasy no longer bears the same relevance and needs to be ramped up insanely to have any impact. As a thought experiment, let’s pretend…

  • Small cap psychedelics stocks – Today’s Idea

    Small cap psychedelics stocks – Today’s Idea

    The psychedelics space is loaded with over-valued unicorns and also-rans, making it difficult for investors to find real growth opportunities. Here are some companies in the sector that have differentiated themselves, let’s examine them and their potential value: Mind Cure Health (MCUR.C) is based in Vancouver, Canada and according to its website is a company…

  • To Invest or Not: Pure Extracts Technologies Corp. (PULL.C)

    To Invest or Not: Pure Extracts Technologies Corp. (PULL.C)

    In this episode, we take a look at a cannabis, hemp and psychedelics extraction company based in British Columbia that goes by the name Pure Extracts Technologies Corp. (PULL.C). The company offers various derivative cannabis products such as Pure Mushrooms, which are daily supplements aimed at boosting the immune system and overall health and wellness;…